Close

Analyst Ratings for Cincor Pharma Inc (CINC) [Neutrals]

CINC Rating Summary

  |   Expand Research on CINC
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 62%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/12/2023 Barclays Leon Wang Downgrade Equalweight
(Overweight)
31.00
(22.00)
28.80
(29.06)
0.9% Details
11/29/2022 Oppenheimer Jay Olson Downgrade Perform
(Outperform)
N/A
(N/A)
26.53
(29.06)
9.54% Details